Academia
A smartphone diagnostic test for COVID-19 being developed by a University of Utah researcher holds the potential for quick, accurate testing without the need for individuals to go to a healthcare facility. A prototype may be ready within two to three months.
A study published by researchers from The Mount Sinai Hospital/Mount Sinai School of Medicine on May 6 revealed that blood thinners may slow down clotting in patients with COVID-19, ultimately improving their chances of survival.
While it may be quicker than developing a vaccine, finding the right drugs to treat the disease will still be tricky.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Vaccitech Ltd and the University of Oxford announce an agreement with the UK-based global biopharmaceutical company AstraZeneca for the further development, large-scale manufacture and potential distribution of the COVID-19 vaccine candidate currently being trialled by the University.
These “backpacks” keep key immune cells in a tumor-killing state for up to five days after they approach a tumor.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
AstraZeneca and the University of Oxford have partnered on the global development and distribution of Oxford’s COVID-19 vaccine it is developing.
With emergency approval, the Oxford University researchers believe they could have a few million doses of the vaccine available by September if it is proven effective.
Although promising, it’s still unclear if this would actually prevent infection in people.
PRESS RELEASES